Business · 08/05/2024Updated: 10/17/2026 · 1 min read

FDA Announces Public Meeting of Peripheral and Central Nervous System Drugs Advisory Committee

The FDA is hosting a public meeting of the Peripheral and Central Nervous System Drugs Advisory Committee to gather input on a biologics license application for Donanemab Solution for Intravenous Infusion, and is seeking public comments on the matter.